Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Drugs for Osteoarthritis Pain Revenue 1.4 Market Analysis by Type 1.4.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Oral 1.4.3 Injection 1.4.4 External 1.5 Market by Application 1.5.1 Global Drugs for Osteoarthritis Pain Market Share by Application: 2020 VS 2026 1.5.2 Medical Care 1.5.3 Personal Care 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Drugs for Osteoarthritis Pain Market Perspective (2015-2026) 2.2 Drugs for Osteoarthritis Pain Growth Trends by Regions 2.2.1 Drugs for Osteoarthritis Pain Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Drugs for Osteoarthritis Pain Historic Market Share by Regions (2015-2020) 2.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Drugs for Osteoarthritis Pain Market Growth Strategy 2.3.6 Primary Interviews with Key Drugs for Osteoarthritis Pain Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Drugs for Osteoarthritis Pain Players by Market Size 3.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2015-2020) 3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2015-2020) 3.1.3 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Drugs for Osteoarthritis Pain Market Concentration Ratio 3.2.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2019 3.3 Drugs for Osteoarthritis Pain Key Players Head office and Area Served 3.4 Key Players Drugs for Osteoarthritis Pain Product Solution and Service 3.5 Date of Enter into Drugs for Osteoarthritis Pain Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2015-2020) 4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2021-2026) 5 Drugs for Osteoarthritis Pain Breakdown Data by Application (2015-2026) 5.1 Global Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) 5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Drugs for Osteoarthritis Pain Market Size (2015-2020) 6.2 Drugs for Osteoarthritis Pain Key Players in North America (2019-2020) 6.3 North America Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) 6.4 North America Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) 7 Europe 7.1 Europe Drugs for Osteoarthritis Pain Market Size (2015-2020) 7.2 Drugs for Osteoarthritis Pain Key Players in Europe (2019-2020) 7.3 Europe Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) 7.4 Europe Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) 8 China 8.1 China Drugs for Osteoarthritis Pain Market Size (2015-2020) 8.2 Drugs for Osteoarthritis Pain Key Players in China (2019-2020) 8.3 China Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) 8.4 China Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) 9 Japan 9.1 Japan Drugs for Osteoarthritis Pain Market Size (2015-2020) 9.2 Drugs for Osteoarthritis Pain Key Players in Japan (2019-2020) 9.3 Japan Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) 9.4 Japan Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Drugs for Osteoarthritis Pain Market Size (2015-2020) 10.2 Drugs for Osteoarthritis Pain Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) 10.4 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) 11 India 11.1 India Drugs for Osteoarthritis Pain Market Size (2015-2020) 11.2 Drugs for Osteoarthritis Pain Key Players in India (2019-2020) 11.3 India Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) 11.4 India Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Drugs for Osteoarthritis Pain Market Size (2015-2020) 12.2 Drugs for Osteoarthritis Pain Key Players in Central & South America (2019-2020) 12.3 Central & South America Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) 12.4 Central & South America Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction 13.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Johnson & Johnson 13.2.1 Johnson & Johnson Company Details 13.2.2 Johnson & Johnson Business Overview and Its Total Revenue 13.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction 13.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 13.2.5 Johnson & Johnson Recent Development 13.3 GlaxoSmithKline 13.3.1 GlaxoSmithKline Company Details 13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction 13.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 13.3.5 GlaxoSmithKline Recent Development 13.4 Bayer 13.4.1 Bayer Company Details 13.4.2 Bayer Business Overview and Its Total Revenue 13.4.3 Bayer Drugs for Osteoarthritis Pain Introduction 13.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 13.4.5 Bayer Recent Development 13.5 Eli Lilly 13.5.1 Eli Lilly Company Details 13.5.2 Eli Lilly Business Overview and Its Total Revenue 13.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction 13.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 13.5.5 Eli Lilly Recent Development 13.6 Novartis 13.6.1 Novartis Company Details 13.6.2 Novartis Business Overview and Its Total Revenue 13.6.3 Novartis Drugs for Osteoarthritis Pain Introduction 13.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 13.6.5 Novartis Recent Development 13.7 Sanofi 13.7.1 Sanofi Company Details 13.7.2 Sanofi Business Overview and Its Total Revenue 13.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction 13.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 13.7.5 Sanofi Recent Development 13.8 Horizon Pharma 13.8.1 Horizon Pharma Company Details 13.8.2 Horizon Pharma Business Overview and Its Total Revenue 13.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction 13.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 13.8.5 Horizon Pharma Recent Development 13.9 Abbott 13.9.1 Abbott Company Details 13.9.2 Abbott Business Overview and Its Total Revenue 13.9.3 Abbott Drugs for Osteoarthritis Pain Introduction 13.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 13.9.5 Abbott Recent Development 13.10 Mylan 13.10.1 Mylan Company Details 13.10.2 Mylan Business Overview and Its Total Revenue 13.10.3 Mylan Drugs for Osteoarthritis Pain Introduction 13.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 13.10.5 Mylan Recent Development 13.11 Daiichi Sankyo 10.11.1 Daiichi Sankyo Company Details 10.11.2 Daiichi Sankyo Business Overview and Its Total Revenue 10.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction 10.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 10.11.5 Daiichi Sankyo Recent Development 13.12 TEVA 10.12.1 TEVA Company Details 10.12.2 TEVA Business Overview and Its Total Revenue 10.12.3 TEVA Drugs for Osteoarthritis Pain Introduction 10.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 10.12.5 TEVA Recent Development 13.13 Almatica Pharma 10.13.1 Almatica Pharma Company Details 10.13.2 Almatica Pharma Business Overview and Its Total Revenue 10.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction 10.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 10.13.5 Almatica Pharma Recent Development 13.14 Astellas Pharma 10.14.1 Astellas Pharma Company Details 10.14.2 Astellas Pharma Business Overview and Its Total Revenue 10.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction 10.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 10.14.5 Astellas Pharma Recent Development 13.15 Tide Pharmaceutical 10.15.1 Tide Pharmaceutical Company Details 10.15.2 Tide Pharmaceutical Business Overview and Its Total Revenue 10.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction 10.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 10.15.5 Tide Pharmaceutical Recent Development 13.16 Iroko Pharmaceuticals 10.16.1 Iroko Pharmaceuticals Company Details 10.16.2 Iroko Pharmaceuticals Business Overview and Its Total Revenue 10.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction 10.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 10.16.5 Iroko Pharmaceuticals Recent Development 13.17 Hengrui Pharmaceutical 10.17.1 Hengrui Pharmaceutical Company Details 10.17.2 Hengrui Pharmaceutical Business Overview and Its Total Revenue 10.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction 10.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 10.17.5 Hengrui Pharmaceutical Recent Development 13.18 Abiogen Pharma 10.18.1 Abiogen Pharma Company Details 10.18.2 Abiogen Pharma Business Overview and Its Total Revenue 10.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction 10.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) 10.18.5 Abiogen Pharma Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Drugs for Osteoarthritis Pain Key Market Segments Table 2. Key Players Covered: Ranking by Drugs for Osteoarthritis Pain Revenue Table 3. Ranking of Global Top Drugs for Osteoarthritis Pain Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Oral Table 6. Key Players of Injection Table 7. Key Players of External Table 8. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Drugs for Osteoarthritis Pain Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Drugs for Osteoarthritis Pain Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Drugs for Osteoarthritis Pain Market Share by Regions (2015-2020) Table 12. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Drugs for Osteoarthritis Pain Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Drugs for Osteoarthritis Pain Market Growth Strategy Table 18. Main Points Interviewed from Key Drugs for Osteoarthritis Pain Players Table 19. Global Drugs for Osteoarthritis Pain Revenue by Players (2015-2020) (Million US$) Table 20. Global Drugs for Osteoarthritis Pain Market Share by Players (2015-2020) Table 21. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Osteoarthritis Pain as of 2019) Table 22. Global Drugs for Osteoarthritis Pain by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Drugs for Osteoarthritis Pain Product Solution and Service Table 25. Date of Enter into Drugs for Osteoarthritis Pain Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (Million US$) Table 28. Global Drugs for Osteoarthritis Pain Market Size Share by Type (2015-2020) Table 29. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2021-2026) Table 30. Global Drugs for Osteoarthritis Pain Market Size Share by Application (2015-2020) Table 31. Global Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (Million US$) Table 32. Global Drugs for Osteoarthritis Pain Market Size Share by Application (2021-2026) Table 33. North America Key Players Drugs for Osteoarthritis Pain Revenue (2019-2020) (Million US$) Table 34. North America Key Players Drugs for Osteoarthritis Pain Market Share (2019-2020) Table 35. North America Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (Million US$) Table 36. North America Drugs for Osteoarthritis Pain Market Share by Type (2015-2020) Table 37. North America Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (Million US$) Table 38. North America Drugs for Osteoarthritis Pain Market Share by Application (2015-2020) Table 39. Europe Key Players Drugs for Osteoarthritis Pain Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Drugs for Osteoarthritis Pain Market Share (2019-2020) Table 41. Europe Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (Million US$) Table 42. Europe Drugs for Osteoarthritis Pain Market Share by Type (2015-2020) Table 43. Europe Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (Million US$) Table 44. Europe Drugs for Osteoarthritis Pain Market Share by Application (2015-2020) Table 45. China Key Players Drugs for Osteoarthritis Pain Revenue (2019-2020) (Million US$) Table 46. China Key Players Drugs for Osteoarthritis Pain Market Share (2019-2020) Table 47. China Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (Million US$) Table 48. China Drugs for Osteoarthritis Pain Market Share by Type (2015-2020) Table 49. China Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (Million US$) Table 50. China Drugs for Osteoarthritis Pain Market Share by Application (2015-2020) Table 51. Japan Key Players Drugs for Osteoarthritis Pain Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Drugs for Osteoarthritis Pain Market Share (2019-2020) Table 53. Japan Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (Million US$) Table 54. Japan Drugs for Osteoarthritis Pain Market Share by Type (2015-2020) Table 55. Japan Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (Million US$) Table 56. Japan Drugs for Osteoarthritis Pain Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Drugs for Osteoarthritis Pain Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Drugs for Osteoarthritis Pain Market Share (2019-2020) Table 59. Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Drugs for Osteoarthritis Pain Market Share by Type (2015-2020) Table 61. Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Drugs for Osteoarthritis Pain Market Share by Application (2015-2020) Table 63. India Key Players Drugs for Osteoarthritis Pain Revenue (2019-2020) (Million US$) Table 64. India Key Players Drugs for Osteoarthritis Pain Market Share (2019-2020) Table 65. India Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (Million US$) Table 66. India Drugs for Osteoarthritis Pain Market Share by Type (2015-2020) Table 67. India Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (Million US$) Table 68. India Drugs for Osteoarthritis Pain Market Share by Application (2015-2020) Table 69. Central & South America Key Players Drugs for Osteoarthritis Pain Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Drugs for Osteoarthritis Pain Market Share (2019-2020) Table 71. Central & South America Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Drugs for Osteoarthritis Pain Market Share by Type (2015-2020) Table 73. Central & South America Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Drugs for Osteoarthritis Pain Market Share by Application (2015-2020) Table 75. Pfizer Company Details Table 76. Pfizer Business Overview Table 77. Pfizer Product Table 78. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 79. Pfizer Recent Development Table 80. Johnson & Johnson Company Details Table 81. Johnson & Johnson Business Overview Table 82. Johnson & Johnson Product Table 83. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 84. Johnson & Johnson Recent Development Table 85. GlaxoSmithKline Company Details Table 86. GlaxoSmithKline Business Overview Table 87. GlaxoSmithKline Product Table 88. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 89. GlaxoSmithKline Recent Development Table 90. Bayer Company Details Table 91. Bayer Business Overview Table 92. Bayer Product Table 93. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 94. Bayer Recent Development Table 95. Eli Lilly Company Details Table 96. Eli Lilly Business Overview Table 97. Eli Lilly Product Table 98. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 99. Eli Lilly Recent Development Table 100. Novartis Company Details Table 101. Novartis Business Overview Table 102. Novartis Product Table 103. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 104. Novartis Recent Development Table 105. Sanofi Company Details Table 106. Sanofi Business Overview Table 107. Sanofi Product Table 108. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 109. Sanofi Recent Development Table 110. Horizon Pharma Business Overview Table 111. Horizon Pharma Product Table 112. Horizon Pharma Company Details Table 113. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 114. Horizon Pharma Recent Development Table 115. Abbott Company Details Table 116. Abbott Business Overview Table 117. Abbott Product Table 118. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 119. Abbott Recent Development Table 120. Mylan Company Details Table 121. Mylan Business Overview Table 122. Mylan Product Table 123. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 124. Mylan Recent Development Table 125. Daiichi Sankyo Company Details Table 126. Daiichi Sankyo Business Overview Table 127. Daiichi Sankyo Product Table 128. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 129. Daiichi Sankyo Recent Development Table 130. TEVA Company Details Table 131. TEVA Business Overview Table 132. TEVA Product Table 133. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 134. TEVA Recent Development Table 135. Almatica Pharma Company Details Table 136. Almatica Pharma Business Overview Table 137. Almatica Pharma Product Table 138. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 139. Almatica Pharma Recent Development Table 140. Astellas Pharma Company Details Table 141. Astellas Pharma Business Overview Table 142. Astellas Pharma Product Table 143. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 144. Astellas Pharma Recent Development Table 145. Tide Pharmaceutical Company Details Table 146. Tide Pharmaceutical Business Overview Table 147. Tide Pharmaceutical Product Table 148. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 149. Tide Pharmaceutical Recent Development Table 150. Iroko Pharmaceuticals Company Details Table 151. Iroko Pharmaceuticals Business Overview Table 152. Iroko Pharmaceuticals Product Table 153. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 154. Iroko Pharmaceuticals Recent Development Table 155. Hengrui Pharmaceutical Company Details Table 156. Hengrui Pharmaceutical Business Overview Table 157. Hengrui Pharmaceutical Product Table 158. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 159. Hengrui Pharmaceutical Recent Development Table 160. Abiogen Pharma Company Details Table 161. Abiogen Pharma Business Overview Table 162. Abiogen Pharma Product Table 163. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (Million US$) Table 164. Abiogen Pharma Recent Development Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Global Drugs for Osteoarthritis Pain Market Share by Type: 2020 VS 2026 Figure 2. Oral Features Figure 3. Injection Features Figure 4. External Features Figure 5. Global Drugs for Osteoarthritis Pain Market Share by Application: 2020 VS 2026 Figure 6. Medical Care Case Studies Figure 7. Personal Care Case Studies Figure 8. Drugs for Osteoarthritis Pain Report Years Considered Figure 9. Global Drugs for Osteoarthritis Pain Market Size YoY Growth 2015-2026 (US$ Million) Figure 10. Global Drugs for Osteoarthritis Pain Market Share by Regions: 2020 VS 2026 Figure 11. Global Drugs for Osteoarthritis Pain Market Share by Regions (2021-2026) Figure 12. Porter's Five Forces Analysis Figure 13. Global Drugs for Osteoarthritis Pain Market Share by Players in 2019 Figure 14. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Osteoarthritis Pain as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2019 Figure 16. North America Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2020) (Million US$) Figure 17. Europe Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2020) (Million US$) Figure 18. China Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2020) (Million US$) Figure 21. India Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Central & South America Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 29. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 31. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 35. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 37. Horizon Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 39. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 41. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 43. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 45. TEVA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 47. Almatica Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 49. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 51. Tide Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 53. Iroko Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 55. Hengrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 57. Abiogen Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 58. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020) Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

Pfizer Johnson & Johnson GlaxoSmithKline Bayer Eli Lilly Novartis Sanofi Horizon Pharma Abbott Mylan Daiichi Sankyo TEVA Almatica Pharma Astellas Pharma Tide Pharmaceutical Iroko Pharmaceuticals Hengrui Pharmaceutical Abiogen Pharma